openPR Logo
Press release

Dr. Rubenstein expert presenter at one of a kind inter-disciplinary Non-Pharmacological Chronic Pain Symposium

06-28-2018 08:47 AM CET | Health & Medicine

Press release from: Craig S. Rubenstein DC PC

Dr. Rubenstein expert presenter at inter-disciplinary Non-Pharmacological Pain Symposium

Dr. Rubenstein expert presenter at inter-disciplinary Non-Pharmacological Pain Symposium

Chiropractor and Clinical Nutritionist, Dr. Craig S. Rubenstein invited as nutritional authority at the 1st Annual Non-Pharmalogical and Complementary Medicine for the Treatment of Chronic Pain Symposium

This one of a kind conference was hosted by Mather Hospital Northwell Health’s Back and Neck Pain Center at John T. Mather Hospital, NY, a leader in integrated and interdisciplinary spine care.

This inter-disciplinary symposium was attended by practitioners in multiple fields including anesthesiologists, psychiatrists, psychologists, social workers, physical therapists, acupuncturists, surgeons, chiropractors, pain management specialists, primary care and internal medicine physicians, as well as registered nurses and nurse practitioners.

Dr. Rubenstein is affiliated with Mather Hospital‘s Chiropractic Collaboration Program since it’s inception. Dr. Rubenstein has also obtained certification as a Primary Spine Care Practitioner.

“A breakthrough, is the only way I can explain both the Non-Pharma Symposium and Mather Hospital’s Back and Neck Pain Center’s integrated approach to chronic pain. It is the first of its kind anywhere in the area“, states Dr. Rubenstein.

“Where else, for the first time could you find Chiropractor’s sitting amongst their medical colleagues in a collaborative fashion, to discuss non opiate pain options, looking only to enhance patient outcomes.”

This event gives Chiropractor’s and their medical counterparts a setting to present and discuss each professions expertise in dealing with chronic pain and a forum to create an understanding of how to integrate each professions techniques.

The Non-Pharmalogical and Complementary Medicine for the Treatment of Chronic Pain Symposium was moderated by administrative director and chiropractor, David J. BenEliyahu.

The format for the symposium included nine specific nonpharmacological approaches to chronic pain presentations. Dr. Rubenstein explains that the different lectures ranged in topics from implantation of pain neuromodulators to yoga, aromatherapy and nutritional supplementation.

Other presentations revolved around anti-inflammatory diets, the psychology of mindfulness, acupuncture and physical therapy.

Dr. Rubenstein‘s role as an expert presenter along with other practitioners on the speaker panel was to in enlighten their fellow practitioners on specific nonpharmacological approaches to chronic pain.

Dr. Rubenstein‘s presentation was on the use of herbs, vitamins and other nutraceuticals to reduce or eliminate the need for opiates.

Dr. Rubenstein maintains two chiropractic care clinics, one in New York City and the other in Medford, Long Island.

Along with being a primary spine care practitioner, Dr. Rubenstein is also a certified clinical nutritionist and diplomate of the American clinical board of nutrition. Dr. Rubenstein is also eligible to sit for his diplomate exams in both applied kinesiology and chiropractic neurology. Due to Dr. Rubenstein‘s training, he treats patients with multi faceted approach which blends chiropractic, functional neurology, clinical nutrition and applied kinesiology.

Craig S. Rubenstein DC PC
258 Granny Rd.
Medford, NY 11763
33 W. 46th St. 5th Fl.
NYC, NY 10036

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Rubenstein expert presenter at one of a kind inter-disciplinary Non-Pharmacological Chronic Pain Symposium here

News-ID: 1100862 • Views:

More Releases from Craig S. Rubenstein DC PC

Chiropractor, Kinesiologist and Nutrition Expert Craig S. Rubenstein, Chosen to Treat Ultra Marathon Runner Trishul Cherns During 6 Days in The Dome, Ultrarunning Competition
Chiropractor, Kinesiologist and Nutrition Expert Craig S. Rubenstein, Chosen to …
Sixty-two Year Old Ultra Marathon Running legend Trishul Cherns has chosen expert kinesiologist and chiropractor Craig S. Rubenstein to help him run over two and a half full marathons per day for six days straight at “The Redux” “6 Days in The Dome” ultra running competition. Trishul, a veteran to the sport is now sixty-two years old and has for decades employed chiropractors specializing in Applied Kinesiology to treat him

More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and